Evidence map›Paper›PMID 33908022›Full record

ReviewHuman cell2021

Current insight into the functions of microRNAs in common human hair loss disorders: a mini review.

Sujay Paul, Iván Licona-Vázquez, Francisco I Serrano-Cano, Natalia Frías-Reid, Carolina Pacheco-Dorantes, Surajit Pathak, Samik Chakraborty, Aashish Srivastava

Abstract readReview
PubMed Publisher
In one paragraph

Review in Human cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review.Recent advances in inflammation & allergy drug discovery · 2022
    Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Sujay PaulTecnologico de Monterrey, School of Engineering and Sciences, Av. Epigmenio González No. 500 Fracc. San Pablo, 76130, Querétaro, México. spaul@tec.mx.ORCID http://orcid.org/0000-0001-5024-7261
Iván Licona-Vázquez *Tecnologico de Monterrey, School of Engineering and Sciences, Av. Epigmenio González No. 500 Fracc. San Pablo, 76130, Querétaro, México.
Francisco I Serrano-Cano *Tecnologico de Monterrey, School of Engineering and Sciences, Av. Epigmenio González No. 500 Fracc. San Pablo, 76130, Querétaro, México.
Natalia Frías-Reid *Tecnologico de Monterrey, School of Engineering and Sciences, Av. Epigmenio González No. 500 Fracc. San Pablo, 76130, Querétaro, México.
Carolina Pacheco-Dorantes *Tecnologico de Monterrey, School of Engineering and Sciences, Av. Epigmenio González No. 500 Fracc. San Pablo, 76130, Querétaro, México.
Surajit PathakDepartment of Medical Biotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai, 603103, Tamil Nadu, India.
Samik ChakrabortyDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Aashish SrivastavaSection of Bioinformatics, Clinical Laboratory, Haukeland University Hospital, 5021, Bergen, Norway.
Tecnológico de Monterrey · MXBoston Children's Hospital · USChettinad Academy of Research and Education · INHaukeland University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alopecia areata (AA) and Androgenic alopecia (AGA) are the most common multifactorial hair loss disorders that have a serious psychological impact on the affected individuals, while frontal fibrosing alopecia (FFA) is comparatively less common. However, due to the unknown etiology and the effect of many adverse factors, the prognosis of these conditions is challenging to predict. Moreover, no approved therapy has been available to date to prevent or treat these disorders. MicroRNAs (miRNAs) are a group of evolutionary conserved small non-coding RNA molecules with significant roles in the posttranscriptional gene regulation either through mRNA degradation or translational repression. A number of biological processes are controlled by these molecules, including cell growth and differentiation, proliferation, inflammation, immune responses, and apoptosis. Recently, a handful of studies have demonstrated the impact of miRNAs on common hair loss-related disorders; however, the exhaustive molecular mechanisms are still unclear. In this review, we discussed the functional implications of miRNAs in common hair loss-related disorders and addressed their efficacy to be used for theranostic purposes shortly.

Indexed as

AlopeciaGene Regulatory NetworksHumansMicroRNAsPrecision MedicineProtein BiosynthesisRNA, MessengerTranscription, GeneticMicroRNAsRNA, MessengerAlopeciaBiomarkerMicroRNATheranosticT lymphocytes

Identifiers

PMID33908022
OpenAlexW3158909311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.